Research has shown that repeated propofol administration might lead to long-term cognitive deficits, heightened pro-inflammatory responses, and increased activation of NF-κB and NLRP3 inflammasomes in the brain [65,69], leading to cognitive dysfunction. This evidence concerns the gene NFKB1 and Cognitive impairment.